A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058

NCT05803850 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

IPF

Interventions

DRUG: HNC1058 Capsules

Sponsor

Guangzhou Henovcom Bioscience Co. Ltd.